Font size
S
M
L
XL
WorksheetsGEM Respiratory Drugs SBAs
Total questions: 96
Worksheet time: 2hrs 36mins
Name
Class
Date
1.
A 24-year-old woman with a history of childhood asthma presents to her GP feeling increasingly short of breath and wheezy over the past week. She reports having been using her reliever inhaler more frequently. The GP reviews her medication and decides to prescribe a short-acting beta-2 agonist for immediate symptom relief. Which of the following drugs is the GP most likely to prescribe?
a)
Ipratropium bromide
b)
Salmeterol
c)
Salbutamol
d)
Beclometasone
e)
Montelukast
2.
A 7-year-old boy is brought to the Emergency Department during an acute asthma exacerbation. He is tachypnoeic, using his accessory muscles, and has a peak expiratory flow of 40% predicted. After initiating oxygen therapy, the medical team administers a bronchodilator via a nebuliser for rapid relief of bronchoconstriction. This nebulised drug most directly belongs to which class of medications?
a)
Anticholinergic
b)
Leukotriene receptor antagonist
c)
Inhaled corticosteroid
d)
Short-acting beta-2 agonist
e)
Methylxanthine
3.
A researcher is studying the molecular pharmacology of drugs used in obstructive airways disease. She is investigating a common reliever medication that acts on a specific G-protein coupled receptor. Activation of which receptor by this drug primarily mediates its therapeutic bronchodilator effect?
a)
Alpha-1 adrenergic receptor
b)
Muscarinic M3 receptor
c)
Beta-2 adrenergic receptor
d)
Histamine H1 receptor
e)
Dopamine D2 receptor
4.
A medical student is revising the cellular actions of asthma medications. They note that one key reliever drug works by increasing the intracellular concentration of a specific second messenger within airway smooth muscle cells. Which second messenger is increased as the direct result of this drug's action on its receptor?
a)
Inositol trisphosphate (IP3)
b)
Diacylglycerol (DAG)
c)
Guanylate cyclase
d)
Cyclic adenosine monophosphate (cAMP)
e)
Calcium ions (Ca2+)
5.
A 58-year-old man with chronic obstructive pulmonary disease (COPD) is reviewed in clinic. He experiences daily breathlessness and wheeze. His current medication includes tiotropium. The consultant advises adding an inhaler for immediate relief of breakthrough symptoms. Which of the following is the most appropriate addition for this purpose?
a)
Regular salmeterol
b)
As-needed salbutamol
c)
Oral prednisolone
d)
Regular beclometasone
e)
Azithromycin
6.
A 19-year-old university student with asthma is seen in A&E with a severe exacerbation. He is anxious, tremulous, and tachycardic. He admits to overusing his reliever inhaler excessively over the past 24 hours due to severe symptoms before coming to hospital. Which of the following adverse effects is most directly attributable to the systemic absorption of his reliever medication?
a)
Bradycardia
b)
Constipation
c)
Fine tremor
d)
Sedation
e)
Hypokalaemia
7.
A 45-year-old patient with severe asthma is being reviewed in a specialist respiratory clinic. Their symptoms are not fully controlled on a moderate-dose inhaled corticosteroid alone. The consultant decides to initiate a maintenance bronchodilator that has both a long duration of action and a relatively rapid onset. Which of the following long-acting beta-2 agonists (LABAs) is the consultant most likely to add to the regimen?
a)
Salbutamol
b)
Ipratropium
c)
Formoterol
d)
Theophylline
e)
Montelukast
8.
A practice nurse is counselling a patient on their new combination inhaler for asthma. She explains that the inhaler contains two medicines: one to reduce background inflammation daily and another to provide sustained relaxation of the airway muscles for 12 hours. The bronchodilator component in this combination inhaler belongs to which class of drugs?
a)
Short-acting muscarinic antagonist (SAMA)
b)
Long-acting beta-2 agonist (LABA)
c)
Leukotriene receptor antagonist (LTRA)
d)
Phosphodiesterase inhibitor
e)
Inhaled corticosteroid (ICS)
9.
During a pharmacology tutorial, students discuss maintenance therapies for COPD. One drug is highlighted for its role in preventing breathlessness by continuously stimulating receptors on bronchial smooth muscle. What is the primary molecular target through which this drug exerts its prolonged bronchodilator effect?
a)
Inhibition of phosphodiesterase-4
b)
Antagonism of the muscarinic M3 receptor
c)
Agonism of the beta-2 adrenergic receptor
d)
Blockade of the cysteinyl leukotriene receptor
e)
Activation of the glucocorticoid receptor
10.
A patient with COPD is stable on a combination inhaler containing formoterol and budesonide. The GP explains that the formoterol component works by initiating a signalling cascade inside the airway muscle cells that leads to relaxation. What is the key intracellular event that directly follows formoterol binding to its receptor, leading to muscle relaxation?
a)
Decrease in intracellular cyclic AMP (cAMP)
b)
Increase in intracellular inositol trisphosphate (IP3)
c)
Activation of adenylate cyclase
d)
Inhibition of protein kinase A
e)
Opening of calcium channels
11.
A 35-year-old woman with asthma suffers nocturnal symptoms and exercise-induced breathlessness despite using a standard-dose inhaled corticosteroid. Her asthma control test score is 17. The consultant decides to add a long-acting bronchodilator to her regimen. In which of the following forms is formoterol most appropriately initiated for this patient's asthma?
a)
As a monotherapy inhaler
b)
In a fixed-dose combination inhaler with an inhaled corticosteroid
c)
As an oral tablet twice daily
d)
Via a nebuliser for regular use
e)
As an injectable solution
12.
A 60-year-old man with COPD is started on a formoterol-containing inhaler. At his follow-up appointment, he reports feeling a slight shaking in his hands shortly after taking his morning dose, which tends to settle within an hour. He is otherwise well. Which of the following is the most likely cause of this patient's reported symptom?
a)
Candidiasis of the oropharynx
b)
Systemic corticosteroid effects
c)
Beta-2 receptor stimulation in skeletal muscle
d)
Anticholinergic side effects
e)
Hypersensitivity reaction
13.
A 52-year-old woman with moderate persistent asthma is being stepped up from a reliever and low-dose steroid inhaler. Her consultant prescribes a new maintenance inhaler to be used twice daily, which contains a steroid and a long-acting bronchodilator with a slow onset of action. Which long-acting beta-2 agonist is most likely contained in this combination inhaler?
a)
Formoterol
b)
Salmeterol
c)
Salbutamol
d)
Vilanterol
e)
Indacaterol
14.
A practice pharmacist is reconciling a patient's medications for COPD. The patient uses a "preventer" inhaler morning and night that the pharmacist notes contains two active ingredients to reduce exacerbations and improve lung function. In this combination inhaler, which class does the long-lasting bronchodilator component belong to?
a)
Short-acting beta-2 agonist (SABA)
b)
Long-acting muscarinic antagonist (LAMA)
c)
Long-acting beta-2 agonist (LABA)
d)
Inhaled corticosteroid (ICS)
e)
Phosphodiesterase-4 inhibitor
15.
In a pharmacology practical, students use isolated bronchial smooth muscle to study the effects of different drugs. Adding salmeterol causes a prolonged relaxation. This effect is completely blocked by pre-treating the tissue with another compound. Which type of drug, if applied first, would most likely block the relaxant effect of salmeterol?
a)
A muscarinic agonist (e.g., pilocarpine)
b)
A non-selective beta-blocker (e.g., propranolol)
c)
A glucocorticoid receptor antagonist
d)
A phosphodiesterase inhibitor (e.g., theophylline)
e)
An anticholinergic (e.g., ipratropium)
16.
A research scientist explains that the prolonged duration of action of salmeterol is due to its unique pharmacokinetic property. Unlike its endogenous counterpart adrenaline, it does not get rapidly taken up into nerve terminals. What property of salmeterol's structure primarily accounts for its long duration of action in the airways?
a)
High water solubility
b)
High lipophilicity and an elongated side-chain
c)
Rapid metabolism by catechol-O-methyltransferase (COMT)
d)
Short plasma half-life
e)
Poor receptor binding affinity
17.
A 40-year-old man with asthma reports frequent nocturnal waking due to breathlessness and needs his salbutamol inhaler 3-4 times per day. He is currently on a moderate-dose beclometasone inhaler. According to BTS/SIGN guidelines, what is the recommended next step? Which therapeutic regimen is most appropriate to improve this patient's control?
a)
Add a short-acting muscarinic antagonist (SAMA)
b)
Add a long-acting beta-2 agonist (LABA) in combination with the ICS
c)
Switch to a high-dose inhaled corticosteroid alone
d)
Add a leukotriene receptor antagonist as monotherapy
e)
Start regular oral prednisolone
18.
A patient with severe COPD is admitted with acute breathlessness and tachycardia. He is found to be overusing his salmeterol/fluticasone inhaler due to anxiety about his symptoms. ECG shows sinus tachycardia and occasional ventricular ectopics. Which of the following adverse effects is most directly related to excessive systemic absorption of the LABA component of his inhaler?
a)
Adrenal suppression
b)
Oral thrush
c)
Tachycardia and palpitations
d)
Urinary retention
e)
Peptic ulceration
19.
A 68-year-old man with a 40-pack-year smoking history presents with progressive exertional dyspnoea and a chronic productive cough. Spirometry confirms a post-bronchodilator FEV1/FVC ratio of 0.58. He is started on a maintenance inhaler to be used once daily. Which of the following once-daily inhalers is most appropriate as a first-line maintenance bronchodilator for his condition?
a)
Salbutamol
b)
Formoterol
c)
Tiotropium
d)
Beclometasone
e)
Montelukast
20.
A 72-year-old woman with COPD and a history of cardiac disease is reviewed. She is currently using a salbutamol inhaler but remains breathless. To reduce her exacerbation frequency and improve exercise tolerance, a consultant prescribes a new dry-powder inhaler that works via a different mechanism to her current reliever. The newly prescribed drug most likely belongs to which class?
a)
Long-acting beta-2 agonist (LABA)
b)
Inhaled corticosteroid (ICS)
c)
Long-acting muscarinic antagonist (LAMA)
d)
Methylxanthine
e)
Leukotriene receptor antagonist (LTRA)
21.
A pharmacology student is studying drugs that cause bronchodilation by interfering with the parasympathetic nervous system's control of airway tone. Antagonism of which specific receptor subtype on airway smooth muscle is primarily responsible for the therapeutic effect of tiotropium?
a)
Beta-2 adrenergic receptor
b)
Nicotinic receptor
c)
Muscarinic M3 receptor
d)
Histamine H1 receptor
e)
Dopamine D2 receptor
22.
A patient with COPD asks how their new tiotropium inhaler works differently from their old salbutamol inhaler. The doctor explains it blocks a natural chemical messenger in the lungs. What is the primary intracellular consequence of this drug blocking its target receptor on airway smooth muscle?
a)
Increased production of cyclic AMP (cAMP)
b)
Inhibition of phosphoinositide hydrolysis and reduced IP3 production
c)
Opening of potassium channels
d)
Inhibition of adenylate cyclase
e)
Increased intracellular calcium influx
23.
A 65-year-old man with stable COPD (GOLD Group B) continues to experience significant breathlessness affecting his daily activities despite smoking cessation and pulmonary rehabilitation. He currently uses salbutamol as needed. According to GOLD guidelines, what is the most appropriate initial regular maintenance therapy to improve his symptoms?
a)
A short-acting beta-2 agonist (SABA) only
b)
A long-acting muscarinic antagonist (LAMA)
c)
A combination of an inhaled corticosteroid and a long-acting beta-2 agonist (ICS/LABA)
d)
Oral theophylline
e)
A leukotriene receptor antagonist
24.
An 80-year-old man with severe COPD is started on tiotropium. At his 4-week review, he reports a persistently dry mouth and has recently been troubled by difficulty initiating urination. He has a history of benign prostatic hyperplasia. Which of the following is the most likely class-wide explanation for these new symptoms?
a)
Beta-1 receptor agonism
b)
Antimuscarinic (anticholinergic) effects
c)
Local corticosteroid effects
d)
Alpha-1 adrenergic blockade
e)
Direct mucosal irritation
25.
A 55-year-old man with COPD presents to the Emergency Department with an acute exacerbation. He is wheezy and tachycardic. Alongside oxygen and corticosteroids, the medical team administers a nebulised bronchodilator that works by a different mechanism to salbutamol. Which drug, often combined with salbutamol in a nebuliser for acute exacerbations, is the team most likely using?
a)
Formoterol
b)
Tiotropium
c)
Ipratropium
d)
Salmeterol
e)
Beclometasone
26.
A practice nurse is teaching a patient about their new inhaler for COPD. She explains that this inhaler works by blocking the effect of a specific neurotransmitter in the lungs, leading to airway relaxation. It is used four times a day for maintenance. This medication belongs to which class of bronchodilators?
a)
Short-acting beta-2 agonist (SABA)
b)
Short-acting muscarinic antagonist (SAMA)
c)
Long-acting muscarinic antagonist (LAMA)
d)
Inhaled corticosteroid (ICS)
e)
Methylxanthine
27.
A patient with COPD is prescribed ipratropium. They ask their GP how it works, and the GP explains it blocks the action of the body's own "rest and digest" nervous system on the lung muscles. Which receptor, normally stimulated by acetylcholine from the vagus nerve, does ipratropium primarily block to cause bronchodilation?
a)
Beta-2 adrenergic receptor
b)
Nicotinic acetylcholine receptor (Nm)
c)
Muscarinic M3 receptor
d)
Histamine H1 receptor
e)
Dopamine D2 receptor
28.
In a pharmacology lab, a researcher adds ipratropium to a sample of bronchial smooth muscle that has been pre-treated with methacholine, a muscarinic agonist that causes contraction. What is the primary molecular mechanism by which ipratropium reverses this contraction?
a)
It acts as an agonist, directly activating inhibitory G-proteins.
b)
It inhibits the enzyme phosphodiesterase, increasing cAMP.
c)
It competitively inhibits acetylcholine from binding to muscarinic receptors.
d)
It activates beta-2 receptors, leading to increased cAMP.
e)
It blocks calcium channels on the muscle cell membrane.
29.
A 70-year-old woman with severe COPD and ischemic heart disease is admitted with an exacerbation. She is very tachycardic, and the team is cautious about using standard first-line bronchodilators due to potential cardiac side effects. Which of the following is a key indication for choosing nebulised ipratropium in this clinical scenario?
a)
First-line monotherapy for chronic asthma
b)
As an adjunct to beta-2 agonists in acute COPD exacerbations, particularly if tachycardia is a concern
c)
First-line maintenance therapy for mild COPD
d)
The treatment of choice for acute severe asthma in adults
e)
Primary therapy for anaphylactic bronchospasm
30.
An elderly patient with COPD complains of a very dry mouth and a bitter metallic taste since starting a new ipratropium inhaler. On review, his inhaler technique is poor, and he does not use a spacer device. What is the most likely pharmacological cause of these symptoms?
a)
Local oropharyngeal candidiasis
b)
Local antimuscarinic (anticholinergic) effects on salivary glands
c)
Systemic beta-2 agonist effects
d)
Hypersensitivity reaction to the drug or its propellant
e)
Stimulation of taste buds by the drug molecules
31.
A 58-year-old man with severe COPD requires triple therapy but has poor inhaler technique. His consultant considers an oral maintenance medication that requires careful dose monitoring due to a narrow therapeutic index. Which oral methylxanthine drug is the consultant considering?
a)
Aminophylline
b)
Theophylline
c)
Caffeine
d)
Doxapram
e)
Montelukast
32.
A patient with difficult-to-control asthma is reviewed in a specialist clinic. They are already on high-dose ICS/LABA. The consultant discusses adding an oral drug that works by inhibiting a specific intracellular enzyme to provide an additional bronchodilator and anti-inflammatory effect. This proposed add-on therapy belongs to which class of drugs?
a)
Leukotriene receptor antagonists (LTRAs)
b)
Long-acting muscarinic antagonists (LAMAs)
c)
Methylxanthines
d)
Monoclonal antibodies
e)
Phosphodiesterase-4 inhibitors
33.
A patient stable on theophylline for COPD is started on ciprofloxacin for a chest infection. One week later, they present with nausea, vomiting, and palpitations. Blood tests reveal a significantly elevated theophylline level. What is the primary pharmacokinetic mechanism for this dangerous interaction?
a)
Ciprofloxacin displaces theophylline from plasma protein binding.
b)
Ciprofloxacin induces theophylline renal excretion.
c)
Ciprofloxacin inhibits the cytochrome P450 enzyme (CYP1A2) that metabolises theophylline.
d)
Ciprofloxacin increases the absorption of theophylline from the gut.
e)
Ciprofloxacin is a competitive antagonist at theophylline's site of action.
34.
Theophylline has multiple proposed mechanisms contributing to its effect in airways disease. While its precise primary mechanism is debated, a key pharmacological action is well-established. Which of the following is a recognised mechanism contributing to theophylline's bronchodilator effect?
a)
Agonism of beta-2 adrenergic receptors
b)
Antagonism of adenosine A2A receptors
c)
Non-selective inhibition of phosphodiesterase (PDE) enzymes
d)
Activation of the glucocorticoid receptor
e)
Blockade of muscarinic M3 receptors
35.
A patient with chronic, severe, irreversible airways obstruction remains symptomatic despite maximal inhaled therapy (including LAMA/LABA/ICS) and pulmonary rehabilitation. In which of the following scenarios might oral theophylline be considered as an add-on treatment?
a)
First-line therapy for acute asthma in children
b)
As a fourth-line add-on therapy in severe COPD when symptoms persist despite triple inhaled therapy
c)
Primary prevention of exercise-induced bronchoconstriction
d)
First-line maintenance therapy for mild intermittent asthma
e)
The treatment of choice for acute hypercapnic respiratory failure
36.
A patient on maintenance theophylline presents to the Emergency Department with a two-day history of worsening nausea, vomiting, agitation, and sinus tachycardia. They recently started a new medication for heartburn. Which of the following sets of symptoms is most suggestive of theophylline toxicity?
a)
Bradycardia, hypotension, and sedation
b)
Peripheral oedema and weight gain
c)
Tachycardia, nausea/vomiting, and neurological agitation (can progress to seizures)
d)
Acute renal failure and hyperkalaemia
e)
Bronchospasm and urticaria
37.
A 9-year-old boy with asthma and concomitant allergic rhinitis is struggling with adherence to his inhaled corticosteroid. His mother reports he often forgets to use his inhaler. The GP considers adding an oral, once-daily, leukotriene receptor antagonist to his regimen. Which of the following medications is the GP most likely to prescribe?
a)
Zafirlukast
b)
Montelukast
c)
Omalizumab
d)
Theophylline
e)
Prednisolone
38.
A teenager with exercise-induced asthma finds her salbutamol inhaler helpful but wants a preventive treatment she can take before sports. She is prescribed a non-steroidal tablet that works by blocking inflammatory mediators released from mast cells and eosinophils. This preventive tablet belongs to which class of anti-asthma drugs?
a)
Inhaled corticosteroids (ICS)
b)
Long-acting beta-2 agonists (LABA)
c)
Leukotriene receptor antagonists (LTRA)
d)
Mast cell stabilisers
e)
Monoclonal antibodies
39.
A researcher is investigating the inflammatory pathway targeted by montelukast. The drug prevents a specific group of lipid mediators from binding to their G-protein coupled receptor on airway smooth muscle and inflammatory cells. Which inflammatory mediators are specifically antagonised by montelukast?
a)
Prostaglandins and thromboxanes
b)
Histamine and bradykinin
c)
Cysteinyl leukotrienes (LTC4, LTD4, LTE4)
d)
Interleukin-4 and interleukin-13
e)
Complement proteins C3a and C5a
40.
A patient with aspirin-exacerbated respiratory disease (AERD) is prescribed montelukast. The doctor explains that in this condition, taking aspirin leads to an overproduction of certain chemicals that cause bronchospasm, and this drug blocks their effect. By blocking leukotriene receptors, what is the primary physiological effect of montelukast in the airways?
a)
Potentiation of beta-2 agonist effects
b)
Inhibition of leukotriene-mediated bronchoconstriction, oedema, and inflammation
c)
Direct relaxation of airway smooth muscle via increased cAMP
d)
Stabilisation of mast cell membranes to prevent degranulation
e)
Inhibition of phosphodiesterase enzymes
41.
A 35-year-old woman with mild persistent asthma, which is worse during the spring pollen season, experiences predominantly cough and nocturnal symptoms. She is reluctant to start an inhaled corticosteroid. According to guidelines, which of the following is an appropriate use of montelukast for this patient?
a)
First-line monotherapy for all newly diagnosed asthmatics
b)
An alternative first-line preventer therapy in mild persistent asthma, particularly if there is a reluctance to use ICS or prominent allergic/seasonal components
c)
First-line treatment for an acute severe asthma attack
d)
Replacement for an ICS in patients with moderate-severe asthma
e)
Primary therapy for chronic obstructive pulmonary disease (COPD)
42.
Following the initiation of montelukast for asthma in a 12-year-old boy, his parents contact the GP as they are concerned about changes in his mood, including new-onset nightmares and irritability. Which of the following is a recognised, though uncommon, neuropsychiatric adverse effect associated with montelukast?
a)
Peripheral neuropathy
b)
Behavioural disturbances, sleep disorders, and depression
c)
Parkinsonian symptoms
d)
Cerebellar ataxia
e)
Tardive dyskinesia
43.
A 16-year-old girl with newly diagnosed asthma is started on a regular preventer inhaler. She is prescribed a metered-dose inhaler containing a drug that is a synthetic glucocorticoid. The GP emphasises the importance of rinsing her mouth after use. Which of the following inhaled corticosteroids is she most likely to have been prescribed as a common first-line option?
a)
Fluticasone
b)
Beclometasone
c)
Budesonide
d)
Salmeterol
e)
Montelukast
44.
A patient with moderate persistent asthma is using a brown-coloured inhaler twice daily. The practice nurse explains that this medication works by reducing the underlying inflammation in the airways over time, making them less sensitive to triggers. The medication in this brown inhaler belongs to which fundamental class of asthma preventer drugs?
a)
Long-acting bronchodilators
b)
Short-acting relievers
c)
Inhaled corticosteroids (ICS)
d)
Leukotriene receptor antagonists
e)
Monoclonal antibodies
45.
A pharmacology student is studying the mechanism of anti-inflammatory drugs in asthma. They learn that beclometasone, after being activated in the lungs, enters airway cells and binds to a specific intracellular receptor. Binding to which receptor mediates the vast majority of beclometasone's genomic anti-inflammatory effects?
a)
Beta-2 adrenergic receptor
b)
Mineralocorticoid receptor
c)
Glucocorticoid receptor
d)
Oestrogen receptor
e)
Peroxisome proliferator-activated receptor (PPAR-γ)
46.
A patient asks how their regular beclometasone inhaler actually prevents asthma attacks. The doctor explains it works inside the cells of the airway lining to switch off multiple inflammatory pathways. Which of the following is a key genomic action of beclometasone that contributes to its preventive effect in asthma?
a)
Direct bronchodilation of smooth muscle
b)
Inhibition of transcription factors like NF-κB, reducing cytokine production
c)
Stimulation of mast cell degranulation
d)
Inhibition of phosphodiesterase enzymes
e)
Blockade of muscarinic receptors
47.
A 25-year-old man with asthma reports using his salbutamol reliever inhaler 3-4 times per week for daytime symptoms and occasionally at night. He has no symptoms currently. Spirometry is normal. According to the BTS/SIGN stepwise approach, what is the most appropriate initial regular treatment to improve his asthma control?
a)
Continue salbutamol alone
b)
Start a regular low-dose inhaled corticosteroid (e.g., beclometasone)
c)
Start a long-acting beta-2 agonist (LABA)
d)
Start a leukotriene receptor antagonist (LTRA)
e)
Start oral theophylline
48.
An elderly patient with COPD on high-dose beclometasone via a metered-dose inhaler presents with a hoarse voice and painful white patches on the oral mucosa and tongue. They do not use a spacer and rarely rinse their mouth after inhalation. What is the most likely cause of these local adverse effects?
a)
Systemic corticosteroid effects
b)
Local oropharyngeal candidiasis (oral thrush) due to immunosuppression
c)
Allergic contact stomatitis
d)
Viral pharyngitis (e.g., HSV)
e)
Gastro-oesophageal reflux disease (GORD)
49.
A 42-year-old patient with severe eosinophilic asthma is being considered for add-on biologic therapy. Their current high-dose maintenance therapy includes an inhaled corticosteroid known for its high potency and strong receptor binding affinity. Which of the following high-potency inhaled corticosteroids is commonly used in such severe asthma regimens before stepping up to biologics?
a)
Beclometasone
b)
Budesonide
c)
Fluticasone
d)
Ciclesonide
e)
Hydrocortisone
50.
A patient with allergic rhinitis is prescribed a nasal spray to use regularly throughout the pollen season. The pharmacist explains it contains a steroid that works locally to reduce inflammation in the nasal passages. The active ingredient in this nasal spray belongs to which class of medication?
a)
Antihistamine
b)
Decongestant
c)
Anticholinergic
d)
Corticosteroid
e)
Mast cell stabiliser
51.
Fluticasone is a highly lipophilic drug designed for topical activity in the lungs. Its structure ensures it has a strong affinity for its target after it is inhaled and absorbed into airway cells. What is the primary intracellular target that mediates fluticasone's anti-inflammatory effects?
a)
Beta-2 adrenergic receptor
b)
Mineralocorticoid receptor
c)
Glucocorticoid receptor
d)
Phosphodiesterase enzyme
e)
Transcription factor NF-κB
52.
A student is comparing the mechanisms of different asthma drugs. They note that while salbutamol provides rapid relief, fluticasone works more slowly by altering gene expression in inflammatory cells. What is a key anti-inflammatory genomic action of fluticasone in asthma pathogenesis?
a)
Direct inhibition of mast cell degranulation
b)
Transactivation of genes coding for anti-inflammatory proteins (e.g., lipocortin-1)
c)
Blockade of leukotriene receptors on smooth muscle
d)
Stimulation of adenylate cyclase
e)
Inhibition of cyclooxygenase (COX) enzymes
53.
A patient with COPD and a history of frequent exacerbations (≥2 per year) remains breathless and exacerbates despite being on a long-acting bronchodilator (LAMA or LABA). According to GOLD guidelines, in which of the following regimens would fluticasone most appropriately be used for this patient?
a)
As a monotherapy inhaler
b)
In a fixed-dose combination with a long-acting beta-2 agonist (LABA)
c)
As a regular oral tablet
d)
As a first-line treatment for mild COPD
e)
As a substitute for a bronchodilator in all patients
54.
An elderly patient with severe COPD on long-term high-dose fluticasone/salmeterol presents with generalised fatigue, easy bruising, and proximal muscle weakness. Blood tests show a low morning cortisol level. What is the most likely systemic adverse effect of fluticasone in this context?
a)
Hyperglycaemia and glycosuria
b)
Adrenal suppression
c)
Peptic ulcer disease
d)
Osteonecrosis of the hip
e)
Cushingoid appearance with striae
55.
A 65-year-old man is brought to A&E with a suspected organophosphate insecticide poisoning. He is bradycardic, salivating excessively, and has pinpoint pupils. The medical team prepares an antidote derived from the deadly nightshade plant. Which anticholinergic drug is the definitive antidote for this type of poisoning?
a)
Neostigmine
b)
Ipratropium
c)
Atropine
d)
Glycopyrronium
e)
Pralidoxime
56.
Prior to an ophthalmic procedure, an elderly patient is given eye drops that cause pupillary dilation (mydriasis) and paralysis of accommodation (cycloplegia). This prevents the lens from changing shape during surgery. The eye drops used belong to which class of drugs?
a)
Sympathomimetics
b)
Antimuscarinics (Parasympatholytics)
c)
Beta-blockers
d)
Cholinesterase inhibitors
e)
Prostaglandin analogues
57.
A patient receives a large dose of atropine during resuscitation for bradyasystolic cardiac arrest. The drug works by blocking the effects of the parasympathetic neurotransmitter on specific receptors in the heart. Blockade of which receptor subtype on the sinoatrial (SA) node is primarily responsible for the increase in heart rate?
a)
Nicotinic (Nm) receptor
b)
Beta-1 adrenergic receptor
c)
Muscarinic M2 receptor
d)
Muscarinic M3 receptor
e)
Dopamine receptor
58.
During a simulation, an anaesthetist administers atropine before induction to prevent a reflex bradycardia that can occur with certain drugs. A student asks how it prevents this reflex. What is the fundamental pharmacological action of atropine at a molecular level?
a)
It inhibits the enzyme acetylcholinesterase.
b)
It acts as an agonist at muscarinic receptors.
c)
It competitively antagonises the binding of acetylcholine to muscarinic receptors.
d)
It inhibits the release of acetylcholine from nerve endings.
e)
It blocks nicotinic receptors at autonomic ganglia.
59.
A 50-year-old man is scheduled for elective surgery. As part of the premedication, the anaesthetist prescribes an intramuscular injection to be given shortly before theatre. What is a classic indication for pre-operative atropine?
a)
To provide analgesia
b)
To induce anaesthesia
c)
To reduce salivary and bronchial secretions (as an antisialagogue)
d)
To reverse neuromuscular blockade
e)
To treat post-operative nausea and vomiting
60.
A child is brought to A&E after accidentally ingesting berries from a garden plant. On examination, he is agitated, has a flushed, dry skin, widely dilated pupils, and a heart rate of 140 bpm. His temperature is elevated. Which of the following best describes this classic toxidrome?
a)
Cholinergic crisis (SLUDGE syndrome)
b)
Opioid intoxication
c)
Anticholinergic toxidrome ("Red as a beet, dry as a bone, blind as a bat, mad as a hatter, hot as a hare")
d)
Sympathomimetic toxidrome
e)
Serotonin syndrome
61.
A 58-year-old man with hypertension and a history of exercise-induced angina is started on a new medication. The GP chooses a once-daily, water-soluble beta-blocker that is relatively cardioselective and is often used in patients who may be prone to bronchospasm with non-selective agents. Which of the following beta-blockers fits this description?
a)
Propranolol
b)
Atenolol
c)
Labetalol
d)
Carvedilol
e)
Sotalol
62.
A 45-year-old woman presents with symptoms of hyperthyroidism, including palpitations and tremor. While definitive treatment is arranged, the endocrinologist prescribes an oral medication to provide rapid symptomatic control of her tachycardia and anxiety. Which class of drugs is commonly used for this symptomatic purpose in thyrotoxicosis?
a)
Calcium channel blockers
b)
Beta-adrenoceptor antagonists (Beta-blockers)
c)
Benzodiazepines
d)
Antithyroid drugs (e.g., carbimazole)
e)
Alpha-blockers
63.
A patient with stable angina is prescribed atenolol. The cardiologist explains that the drug works by blocking receptors in the heart, which reduces its workload and oxygen demand. Antagonism of which adrenergic receptor subtype is primarily responsible for the beneficial cardiac effects of atenolol in angina?
a)
Alpha-1 receptor
b)
Beta-1 receptor
c)
Beta-2 receptor
d)
Alpha-2 receptor
e)
Dopamine D1 receptor
64.
A medical student is revising how beta-blockers lower blood pressure. They understand that atenolol's effect is not primarily vasodilatory but involves a reduction in cardiac output. By blocking cardiac beta-1 receptors, what is the primary haemodynamic change through which atenolol lowers blood pressure?
a)
Reduction of peripheral vascular resistance
b)
Reduction in heart rate and stroke volume (cardiac output)
c)
Reduction in circulating blood volume
d)
Direct arterial vasodilation
e)
Central suppression of sympathetic outflow
65.
A 62-year-old man is recovering in hospital following an acute myocardial infarction. His echocardiogram shows reduced left ventricular function. He is already on aspirin, a statin, and an ACE inhibitor. According to post-MI secondary prevention guidelines, which of the following medications should be added to his regimen to reduce mortality and the risk of further infarction, provided he has no contraindications?
a)
A short-acting dihydropyridine calcium channel blocker (e.g., nifedipine)
b)
A beta-blocker (e.g., atenolol or bisoprolol)
c)
An alpha-blocker (e.g., doxazosin)
d)
A long-acting nitrate (e.g., isosorbide mononitrate)
e)
A direct vasodilator (e.g., hydralazine)
66.
A 70-year-old man with COPD (but no active wheeze) and ischemic heart disease is started on atenolol for hypertension. At follow-up, he reports increased breathlessness on exertion and a feeling of generalised fatigue and lethargy. Which of the following is a recognised, mechanism-based adverse effect of atenolol that could explain these symptoms?
a)
Hyperkalaemia
b)
Reduced exercise tolerance and fatigue due to blunted chronotropic response
c)
A persistent dry cough
d)
Peripheral oedema
e)
First-dose hypotension
67.
A 28-year-old musician suffers from severe performance anxiety, manifesting as tremor, palpitations, and sweating before important concerts. Her psychiatrist prescribes a non-selective beta-blocker to be taken shortly before performances to control these physical symptoms. Which of the following is the classic non-selective beta-blocker used for this indication?
a)
Atenolol
b)
Metoprolol
c)
Propranolol
d)
Bisoprolol
e)
Labetalol
68.
A patient with a history of migraine is started on a daily oral medication for prophylaxis. The GP explains this drug was originally developed for heart conditions but is also effective in reducing the frequency and severity of migraine attacks. This migraine prophylactic belongs to which class of drugs?
a)
Tricyclic antidepressants (TCAs)
b)
Anticonvulsants (e.g., topiramate)
c)
Calcium channel blockers (e.g., verapamil)
d)
Beta-adrenoceptor antagonists (Beta-blockers)
e)
CGRP monoclonal antibodies
69.
A patient with thyrotoxicosis is prescribed propranolol for symptomatic control of tremor and tachycardia. The doctor warns that it will block the body's normal physiological response to hypoglycaemia. Blockade of which receptor subtype is primarily responsible for masking the tachycardia that normally warns of hypoglycaemia?
a)
Alpha-1 receptor
b)
Beta-1 receptor
c)
Muscarinic M2 receptor
d)
Dopamine receptor
e)
Histamine H1 receptor
70.
A patient with portal hypertension secondary to liver cirrhosis is started on propranolol for primary prophylaxis of variceal bleeding. By which combined haemodynamic mechanism does non-selective beta-blockade reduce portal pressure in this context?
a)
Vasoconstriction of the hepatic artery only
b)
Beta-1 blockade reduces cardiac output, and beta-2 blockade allows unopposed alpha-mediated splanchnic vasoconstriction
c)
Direct relaxation of portal vein smooth muscle
d)
Reduction of circulating blood volume via diuresis
e)
Inhibition of angiotensin II production
71.
A 45-year-old man is referred to cardiology with recurrent episodes of palpitations, anxiety, and headaches. He is diagnosed with a phaeochromocytoma. After initiation of an alpha-blocker (phenoxybenzamine), a second drug is added to control reflex tachycardia. Why must a beta-blocker like propranolol only be started after adequate alpha-blockade in phaeochromocytoma?
a)
To allow time for tumour localization scans
b)
To prevent orthostatic hypotension from the alpha-blocker
c)
To avoid unopposed alpha-adrenergic activity causing a hypertensive crisis
d)
To ensure the beta-blocker does not mask hypoglycaemia
e)
To reduce the risk of bronchospasm
72.
A 60-year-old woman with well-controlled hypertension on propranolol presents to her GP feeling increasingly tired and short of breath. She has a history of childhood asthma but has been asymptomatic for decades. On examination, she has a widespread expiratory wheeze. Which of the following is an absolute contraindication to the use of propranolol that has likely been precipitated here?
a)
Hyperlipidaemia
b)
Gout
c)
Asthma or reversible airways disease
d)
Type 2 Diabetes Mellitus
e)
Psoriasis
73.
A 30-year-old woman is stung by a wasp and rapidly develops widespread urticaria, facial swelling, stridor, and hypotension. The emergency team administers a life-saving drug intramuscularly into her anterolateral thigh. Which drug is the first-line, immediate treatment for this anaphylactic reaction?
a)
Hydrocortisone
b)
Chlorphenamine
c)
Salbutamol
d)
Adrenaline (Epinephrine)
e)
Ipratropium
74.
During a cardiac arrest, a patient in pulseless electrical activity (PEA) is given a drug to increase coronary and cerebral perfusion pressure by causing vasoconstriction and improving the strength of cardiac contractions. This drug, a direct sympathomimetic, belongs to which broad class?
a)
Anticholinergics
b)
Catecholamines
c)
Beta-blockers
d)
Inotropes
e)
Vasopressin analogues
75.
A patient with anaphylaxis receives intramuscular adrenaline. The doctor explains it works on different receptors: one to constrict blood vessels and raise blood pressure, and another to open the airways. Stimulation of which adrenergic receptor subtype is most responsible for the essential vasoconstrictor effect in anaphylaxis?
a)
Beta-1 receptor
b)
Alpha-1 receptor
c)
Beta-2 receptor
d)
Dopamine D1 receptor
e)
Muscarinic M3 receptor
76.
Adrenaline is administered during a cardiac arrest. A medical student asks how it increases the likelihood of return of spontaneous circulation (ROSC). What is a primary mechanism by which adrenaline improves coronary perfusion during CPR?
a)
It causes coronary artery vasodilation.
b)
It decreases myocardial oxygen demand.
c)
It increases aortic diastolic pressure via alpha-1 mediated vasoconstriction.
d)
It stimulates spontaneous cardiac contractions via vagal stimulation.
e)
It acts as a fibrinolytic agent.
77.
A 5-year-old boy with croup is brought to the Emergency Department with marked stridor and intercostal recession. He is agitated and hypoxic. After securing oxygen, the paediatrician decides on a specific pharmacological intervention. Which of the following is a recognised use of nebulised adrenaline in this acute setting?
a)
To treat the underlying viral infection
b)
To reduce laryngeal mucosal oedema and relieve upper airway obstruction
c)
To provide long-term prevention of further croup episodes
d)
To treat associated bronchospasm
e)
As a replacement for systemic corticosteroids
78.
A healthcare professional accidentally injects a large dose of adrenaline intramuscularly instead of a vaccine. The patient immediately becomes pale, tremulous, and complains of a pounding headache. Their heart rate is 150 bpm and blood pressure is 210/110 mmHg. Which of the following is the most likely explanation for this clinical picture?
a)
Anaphylactic reaction to the adrenaline
b)
Excessive alpha and beta-adrenergic stimulation causing severe hypertension, tachycardia, and anxiety
c)
Hypoglycaemic episode
d)
Vasovagal syncope
e)
Acute coronary syndrome
79.
A 25-year-old woman suffers from seasonal allergic rhinitis. She wants a non-sedating treatment she can take daily during the pollen season. The GP prescribes a long-acting, over-the-counter antihistamine. Which of the following is a common second-generation, non-sedating antihistamine used for this purpose?
a)
Chlorphenamine
b)
Diphenhydramine
c)
Cetirizine
d)
Loratadine
e)
Promethazine
80.
A patient presents with chronic idiopathic urticaria, experiencing daily wheals and pruritus. The dermatologist recommends a regular oral medication that blocks the effects of histamine on blood vessels and sensory nerves. Which class of drugs forms the first-line symptomatic treatment for this condition?
a)
Leukotriene receptor antagonists (LTRAs)
b)
H1-antihistamines
c)
Mast cell stabilisers
d)
Corticosteroids
e)
Immunosuppressants
81.
A pharmacology student is studying the mechanism of action of common allergy medications. They note that loratadine works by binding to a specific receptor without activating it, preventing a key inflammatory mediator from having its effect. Which receptor does loratadine competitively antagonise to produce its therapeutic effects?
a)
Histamine H2 receptor
b)
Histamine H1 receptor
c)
Muscarinic M1 receptor
d)
Alpha-1 adrenergic receptor
e)
Serotonin 5-HT2 receptor
82.
A patient asks why their new loratadine tablet doesn't make them drowsy like an old allergy pill they used to take. The GP explains it's due to differences in how the drug interacts with the body. What is the key property of loratadine that minimises central nervous system side effects like sedation?
a)
It is a potent agonist at central histamine receptors.
b)
It is lipophobic and does not readily cross the blood-brain barrier.
c)
It is rapidly metabolised in the liver to an inactive compound.
d)
It has strong anticholinergic (drying) effects.
e)
It is a prodrug activated only in peripheral tissues.
83.
A 10-year-old boy with eczema experiences intense pruritus, especially at night, which exacerbates his skin condition through scratching. His dermatologist recommends a regular oral medication to help control the itch. Which of the following is a primary indication for using a non-sedating antihistamine like loratadine in this context?
a)
To treat the underlying inflammation of eczema
b)
To provide symptomatic relief of pruritus (itching)
c)
To prevent secondary bacterial skin infections
d)
To act as a topical anti-inflammatory agent
e)
To replace topical corticosteroid therapy
84.
A patient starts taking loratadine for hay fever. They report it is effective and does not cause drowsiness. However, they have read online about potential side effects and ask the GP what to look out for. Which of the following is a recognised, though generally mild, potential side effect of loratadine?
a)
Sedation and impaired driving ability
b)
Urinary retention
c)
Headache
d)
Tachycardia and palpitations
e)
Significant weight gain
85.
A patient with chronic spontaneous urticaria is looking for a more effective alternative to their current over-the-counter antihistamine. Their dermatologist suggests switching to a second-generation H1-antagonist that is known for its potent anti-itch effects and may have mild anti-inflammatory properties. Which of the following second-generation antihistamines is the dermatologist most likely to recommend?
a)
Fexofenadine
b)
Cetirizine
c)
Loratadine
d)
Desloratadine
e)
Levocetirizine
86.
During the spring pollen season, a patient presents with rhinorrhoea, sneezing, and itchy eyes. They want a daily tablet that won't make them drowsy at work. The GP prescribes a medication that blocks the action of histamine. To which class of anti-allergy drugs does this prescribed tablet belong?
a)
Intranasal corticosteroids
b)
Mast cell stabilisers
c)
Second-generation H1-antihistamines
d)
Leukotriene receptor antagonists
e)
Decongestants
87.
A researcher is developing a new drug for allergies. They use cetirizine as a reference compound because it is known to bind tightly and selectively to a specific receptor subtype, preventing its natural agonist from causing symptoms. Cetirizine exerts its therapeutic effect primarily through competitive antagonism at which receptor?
a)
Histamine H2 receptor
b)
Histamine H1 receptor
c)
Muscarinic acetylcholine receptor
d)
Serotonin 5-HT3 receptor
e)
Alpha-1 adrenergic receptor
88.
A patient asks why cetirizine helps their hives. The doctor explains it stops histamine, a chemical released during an allergic reaction, from working on the small blood vessels and nerves in the skin. Blocking histamine at the H1 receptor most directly prevents which of the following pathophysiological effects?
a)
Increased gastric acid secretion
b)
Wheal and flare response (triple response of Lewis)
c)
Bronchoconstriction in asthma
d)
Cardiac arrhythmias
e)
Activation of T-lymphocytes
89.
A 40-year-old woman presents with a 6-week history of recurrent, intensely itchy wheals that appear daily and resolve within 24 hours without scarring. A diagnosis of chronic spontaneous urticaria is made. What is the recommended first-line pharmacological treatment for this condition?
a)
A short course of oral prednisolone
b)
A topical potent corticosteroid cream
c)
A first-generation sedating antihistamine at night
d)
A regular, standard-dose second-generation H1-antihistamine (e.g., cetirizine)
e)
An immunosuppressant like ciclosporin
90.
A patient starts taking cetirizine 10mg daily for hay fever. While it controls his symptoms effectively, he mentions feeling slightly more drowsy than usual in the afternoons, though he is still able to function at work. Which of the following is a recognised difference in the side effect profile of cetirizine compared to some other second-generation antihistamines like loratadine or fexofenadine?
a)
It has strong anticholinergic effects (dry mouth, urinary retention).
b)
It has a low but measurable potential to cause sedation in a minority of patients.
c)
It commonly causes significant weight gain.
d)
It is associated with cardiac arrhythmias (torsades de pointes).
e)
It causes severe hepatotoxicity.
91.
A 6-year-old boy is brought to the Emergency Department with acute urticaria and angioedema following a suspected food allergy. After administering adrenaline, the doctor prescribes an antihistamine injection to provide further symptomatic relief. Which first-generation, sedating antihistamine is commonly available in an intramuscular or intravenous formulation for use in acute allergic reactions in a hospital setting?
a)
Loratadine
b)
Cetirizine
c)
Chlorphenamine (Chlorpheniramine)
d)
Fexofenadine
e)
Desloratadine
92.
A patient presents to their GP with a severe cold, complaining of a runny nose and sneezing. The GP prescribes a combination over-the-counter preparation that contains paracetamol, a decongestant, and an agent to reduce rhinorrhoea. The agent that reduces rhinorrhoea in many cold remedies is most likely from which drug class?
a)
Decongestants (sympathomimetics)
b)
First-generation (sedating) antihistamines
c)
Antitussives (cough suppressants)
d)
Expectorants
e)
Non-steroidal anti-inflammatory drugs (NSAIDs)
93.
A pharmacology student is revising the side effects of older medications. They note that chlorphenamine can cause dry mouth, blurred vision, and urinary retention, effects not typically seen with newer antihistamines. These additional side effects occur because chlorphenamine also has significant antagonistic activity at which other receptor type?
a)
Histamine H2 receptors
b)
Alpha-1 adrenergic receptors
c)
Muscarinic acetylcholine receptors
d)
Dopamine D2 receptors
e)
Serotonin 5-HT2 receptors
94.
A patient with an acute allergic rash is given chlorphenamine. The doctor explains it works by blocking histamine, the chemical causing the itch and swelling. How does chlorphenamine achieve this blockade at a molecular level?
a)
It is an irreversible antagonist of the histamine H1 receptor.
b)
It inhibits the release of histamine from mast cells.
c)
It is a competitive reversible antagonist of the histamine H1 receptor.
d)
It is an agonist that desensitises the histamine H1 receptor.
e)
It enzymatically degrades circulating histamine.
95.
An elderly patient with severe pruritus due to cholestatic liver disease is struggling to sleep at night due to constant itching. The dermatologist considers a pharmacological option to relieve the itch and promote sleep. Why might a first-generation antihistamine like chlorphenamine be chosen over a second-generation agent in this specific palliative context?
a)
For its superior anti-inflammatory effect on the liver
b)
For its combined antipruritic and sedative side effect
c)
For its lack of any drug interactions
d)
For its ability to treat the underlying cholestasis
e)
For its longer duration of action
96.
An 80-year-old man with benign prostatic hyperplasia (BPH) is given chlorphenamine for a viral upper respiratory tract infection. Two days later, he presents to A&E in acute urinary retention. What property of chlorphenamine is the most likely cause of this acute complication?
a)
Its alpha-1 adrenergic agonist effect
b)
Its antimuscarinic (anticholinergic) effect on the bladder detrusor muscle
c)
Its diuretic effect
d)
Its ability to cause prostatic hypertrophy
e)
A hypersensitivity reaction to the drug
Reset
